Merck & Co. (MRK)
(Delayed Data from NYSE)
$123.80 USD
-6.02 (-4.64%)
Updated Jun 28, 2024 04:04 PM ET
After-Market: $124.76 +0.96 (0.78%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 241 - 260 ( 396 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for MRK.
Provider: Stock Traders Daily
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R